survey_idno,sid,file_id,vid,name,labl,var_intrvl,var_dcml,var_wgt,var_start_pos,var_end_pos,var_width,var_imputation,var_security,var_respunit,var_qstn_preqtxt,var_qstn_qstnlit,var_qstn_postqtxt,var_qstn_ivulnstr,var_universe,var_sumstat,var_txt,var_catgry,var_codinstr,var_concept,var_format,var_notes ch.sidos.ddi.392.7771_de,1045,F1,V117,eu52a_b,"Wichtigster Gesichtspunkt: therapeutisches Klonen",discrete,0,,1668,1669,2,,,,,"Bei Ihrer Entscheidung, ob man therapeutisches Klonen fördern sollte oder nicht, was war da für Sie der wichtigste Gesichtspunkt: der Aspekt des Nutzens, der Aspekt des Risikos, oder die moralische Vertretbarkeit?",,"Liste vorlegen.",,"[{""value"":""502"",""type"":""vald""},{""value"":""524"",""type"":""invd""},{""value"":""1"",""type"":""min""},{""value"":""3"",""type"":""max""}]",,"[{""value"":""1"",""labl"":""Nutzen f\u00fcr die Gesellschaft"",""stats"":[{""value"":""211"",""type"":""freq"",""wgtd"":null}]},{""value"":""2"",""labl"":""Risiko f\u00fcr die Gesellschaft"",""stats"":[{""value"":""161"",""type"":""freq"",""wgtd"":null}]},{""value"":""3"",""labl"":""Moralische Vertretbarkeit"",""stats"":[{""value"":""130"",""type"":""freq"",""wgtd"":null}]},{""value"":""-9"",""labl"":""Anderer Ballot"",""stats"":[{""value"":""511"",""type"":""freq"",""wgtd"":null}]},{""value"":""-1"",""labl"":""Weiss nicht"",""stats"":[{""value"":""13"",""type"":""freq"",""wgtd"":null}]}]",,,numeric,